Biogen Inc (BIIB)
194.44
+3.99
(+2.10%)
USD |
NASDAQ |
Apr 19, 16:00
194.44
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Assets (Quarterly): 26.84B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.84B |
| September 30, 2023 | 28.19B |
| June 30, 2023 | 25.16B |
| March 31, 2023 | 24.60B |
| December 31, 2022 | 24.55B |
| September 30, 2022 | 24.85B |
| June 30, 2022 | 25.08B |
| March 31, 2022 | 23.61B |
| December 31, 2021 | 23.88B |
| September 30, 2021 | 23.81B |
| June 30, 2021 | 24.47B |
| March 31, 2021 | 23.85B |
| December 31, 2020 | 24.62B |
| September 30, 2020 | 24.93B |
| June 30, 2020 | 25.51B |
| March 31, 2020 | 26.12B |
| December 31, 2019 | 27.23B |
| September 30, 2019 | 27.48B |
| June 30, 2019 | 26.29B |
| March 31, 2019 | 26.45B |
| December 31, 2018 | 25.29B |
| September 30, 2018 | 25.49B |
| June 30, 2018 | 23.95B |
| March 31, 2018 | 26.09B |
| December 31, 2017 | 23.65B |
| Date | Value |
|---|---|
| September 30, 2017 | 23.07B |
| June 30, 2017 | 21.76B |
| March 31, 2017 | 21.20B |
| December 31, 2016 | 22.88B |
| September 30, 2016 | 22.10B |
| June 30, 2016 | 21.51B |
| March 31, 2016 | 20.67B |
| December 31, 2015 | 19.50B |
| September 30, 2015 | 20.73B |
| June 30, 2015 | 16.76B |
| March 31, 2015 | 15.22B |
| December 31, 2014 | 14.31B |
| September 30, 2014 | 13.70B |
| June 30, 2014 | 12.92B |
| March 31, 2014 | 12.23B |
| December 31, 2013 | 11.86B |
| September 30, 2013 | 11.25B |
| June 30, 2013 | 10.84B |
| March 31, 2013 | 10.16B |
| December 31, 2012 | 10.13B |
| September 30, 2012 | 9.631B |
| June 30, 2012 | 9.162B |
| March 31, 2012 | 9.114B |
| December 31, 2011 | 9.050B |
| September 30, 2011 | 8.802B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.61B
Minimum
Mar 2022
28.19B
Maximum
Sep 2023
25.32B
Average
24.93B
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| Bristol-Myers Squibb Co | 95.16B |
| AbbVie Inc | 134.71B |
| Amgen Inc | 97.15B |
| Regeneron Pharmaceuticals Inc | 33.08B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.05B |
| Shareholders Equity (Quarterly) | 14.80B |
| Debt to Equity Ratio | 0.4688 |
| Current Ratio | 1.997 |
| Net Debt Paydown Yield | -0.35% |